Drawing for RESILIA

USPTO serial 50063459

RESILIA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
Historical data usage

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with RESILIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Albert Lee

1 Park PlazaSuite 600Irvine, CA 92614

Goods and services

ClassDescriptionStatusFirst use
005Protein dietary supplements; Natural dietary supplements; Dietary and nutritional supplements; Vitamin and mineral supplements; Weight management supplements; Vitamin supplements; Dietary supplements; Probiotic supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Aug 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 20, 2026NWAPNEW APPLICATION ENTERED—
Aug 20, 2026MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance